Articles about JSE

Cell C listing triggers R5.2bn hit on Blu Label

The company warns of a sharp earnings per share decline after recognising a R5.2 billion loss linked to Cell C’s listing.

Cell C pleases market with maiden numbers

The mobile operator’s maiden results show solid execution, with data-driven growth and prepaid subscriber gains.

iOCO doubles down on share buyback drive

The company repurchases an additional 2 183 365 shares under its ongoing share buyback programme.

iOCO buys back R9.38m shares

The shares were bought at prices ranging between 398 cents and 400 cents per share, for a total consideration of R9.38 million, excluding transaction costs.

2025 marks turning point for Cell C

The company says 2025 marked a turnaround year, highlighted by a return to profitability, a JSE listing, and expanded network, retail and device partnerships.

All set for MultiChoice delisting

The delisting of the video entertainment group will proceed upon commencement of trading on the JSE and A2X on 10 December.

G20 sees UK in tech deals with JSE, Telkom

Prime minister Keir Starmer is set to unveil initiatives to stimulate job creation, unlock private capital and strengthen ties.

FirstRand buys into Optasia ahead of JSE debut

The firm agrees to acquire 20.1% of Optasia, an AI-powered fintech platform that provides people across emerging markets with financial access.

MultiChoice to delist from JSE

Canal+ plans to acquire all remaining MultiChoice shares after more than 90% of shareholders accepted its offer, triggering a compulsory buyout.

Dubai-based fintech firm Optasia eyes JSE listing

The proposed listing aims to provide the company with access to capital to support its expansion, both organically and through potential future acquisitions.

Risk Insights, JSE clash over ESG contract

Conflict emerges over whether the firm’s ESG data contract with the JSE has ended, with both parties presenting differing accounts.

Former EOH director responds to JSE findings

Anushka Bogdanov, founder of ESG data science consultancy Risk Insights, exercises her right of reply to two articles ITWeb recently ran.